The authors reflect on vaccines which can be used against the human papilloma virus. They suggest that in 2014 there are two prophylactic human papilloma virus vaccines that are commercially available. They argue that thee have been several false alarms raised abut the safety of the vaccines which have not been backed by epidemological or biolgical research and have been managed by efforts to ensure vaccination safety.